Navigation Links
AMTC Grad, Julian Silva, Performs with Les Miserables US/Canada Tour in Minneapolis MN Next Week and Shoots New Duck Dynasty Commercial Airing Next Month
Date:7/14/2013

Atlanta, GA (PRWEB) July 14, 2013

AMTC grad Julian Silva has been touring on Les Miserables’ US and Canada Tour 2013 and will be performing in Minneapolis July 30th-August 4th. His Duck Dynasty commercial will be aired in August before the new season begins in September.

The New York Times says, “Thrilling, spectacular and unforgettable.’ The Chicago Tribune says, "Gobsmacking! This new production of this masterpiece is refreshing, rethought and every bit as epic. Not to be missed."

Ten year old singer Julian Silva from Plant City, Florida got off to a great start this year at the Actors, Models and Talent for Christ Winter SHINE event where he won Overall Child Singer, and a few weeks later landed the role in Les Miserables that debuted March 5 and will continue touring all summer.

After belting out The Lion King's “Circle of Life” in front of 50 VIPs representing NBC, BET, VH1, 20th Century Fox, Tyler Perry, Sony, Mattel, DefJam, GMA and more, Julian received 18 callbacks and will sign with an agent after Les Miserables.

During SHINE, he shared the stage with guest stars Mathai ‘The Voice Season 2’, Ben Stillwell ‘Criminal Minds’ and ‘Disney’s Lab Rats’, Alessandra Matkins model for ‘JC Penney’, Brandin Jay Tyler Perry's ‘Meet the Brown’s’ and Disney’s ‘Let it Shine’, Kelsey Sanders, a regular on ‘Wizards of Waverly Place’ and upcoming films: ‘A Matter of Time’ and ‘Rumors of Wars.’

Julian met another famous person who is monumental to the beginning of his singin
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Actors, Models and Talent for Christ Grad Julian Silva Cast in Les Miserables US and Canada Tour 2013 performing in New York April 30-May 5
2. AMTC Grad Julian Silva Cast in Les Miserables U.S. and Canada Tour 2013 Performing in Rochester, NY May 7-12, 2013
3. Metformin Outperforms Common Class of Diabetes Drugs in Study
4. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
5. US performs worst on potentially preventable death rates compared to France, Germany, and the UK
6. UCLA performs first breathing lung transplant in United States
7. FDA Clears Laser for all Critical Steps in Cataract Surgery: Center For Sight Performs the Most LENSAR Laser Procedures in U.S.
8. Worldwide Internet Sensation and Ashland Musician George Dennehy Performs at the Science Museum of Virginia
9. Thailand Performs a Study on Green Tea and Its Effectiveness in Weight Loss
10. Colorado Orthopedic Consultant Performs e-plus™ Total Knee Replacement
11. SpineCenter Atlanta Performs First and Only Endoscopic Spine Surgery in Atlanta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Chicago, IL (PRWEB) , ... September 01, 2015 ... ... Traumeel™ and Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) ... I.A. Injections of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an ...
(Date:9/1/2015)... Toronto, ON (PRWEB) , ... September 01, 2015 ... ... Trade Secrets, a leading retailer of professional hair salons. This highly anticipated partnership ... all of the Curl Keeper™ Styling Collection. Founder Jonathan Torch and the Curly ...
(Date:8/31/2015)... ... 2015 , ... Jvion, the Atlanta-based leader in predictive analytic ... on helping hospital perform under the Center for Medicare & Medicaid Services’ (CMS’s) ... on performance across four domains related to care quality. To receive a reward ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dental ... Western University of Health Sciences to learn more about its integrated approach to ... Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan Bissett, ...
(Date:8/31/2015)... ... August 31, 2015 , ... India Network Foundation, a non-profit ... tool, which summarizes all available plans, plan maximums, pre-existing condition coverage limits and ... help India Network members make an informed decision regarding the care they want ...
Breaking Medicine News(10 mins):Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:Curly Hair Solutions™ Partners With Trade Secrets 2Health News:Jvion Releases Value-Based Purchasing Predictive Use Case 2Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2
... Like general anesthesia without the risksCORONA DEL ... (GA) remains a popular anesthetic for cosmetic ... avoid GA for cosmetic surgery. Unfortunately, the ... behind these safety-first visionaries.The public should not ...
... Feb. 24 Early detection is the key ... as immunoassay testing are,facing fierce competition from evolving ... immunohistochemistry testing. The ability,to prove the clinical ... a,laboratory is one of the essential requirements to ...
... for the company, PercipEnz Technologies, Inc. announces the ... for clinical and translation research data exchange. The ... of the available services and acts as an ... the needs of the cancer centers and multi-disciplinary ...
... efficient, accurate translation and localization services focused on quality and ... it has initiated a new program of adding global business reference material ... existing clients. , ... Chicago, IL (Vocus) February 24, 2009 -- Businesses ...
... track pace, time, distance, and more with Nike+ iPod technology, even when ... Inc will adapt the Nike+ iPod technology to whatever shoe the user ... ... Rock Products, Inc. has released their Universal Nike+ Sensor adapter, called "the ...
... For over a decade starting in 1982, Dr. W. ... in his seminars worldwide. There must now be hundreds ... or have observed the Red Bead Experiment somewhere in ... it is important to document the reactions, feelings and ...
Cached Medicine News:Health News:Cosmetic Surgery: PK Anesthesia Safest Achievable 2Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 2Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 3Health News:Frost & Sullivan: Novel Diagnostics Methods Driving the European Cancer IVD Market Towards Early Detection and Prevention 4Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 2Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 3Health News:Crescendo(tm), the Clinical and Translational Research Exchange, is Launched 4Health News:Argo Translation Adds New Resources for Conducting Global Business to ArgoTrans.com 2Health News:The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.* 2Health News:The Nike+ iPod Sensor Can Be Used by Any Runner with the New Bean Pod.* 3Health News:Wanted - Past Players of Dr. Deming - Red Bead Experiment 2Health News:Wanted - Past Players of Dr. Deming - Red Bead Experiment 3
(Date:8/31/2015)... , Aug. 31, 2015 With ... cytometry is experiencing a rise in active partnerships. ... in underdeveloped nations to quantitate CD4 cell markers ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... the Global Flow Cytometry Market ( http://www.frost.com/nf0e ), ...
(Date:8/31/2015)...  The departments of Drug and Alcohol Programs (DDAP) ... 90 to raise awareness for International Overdose Awareness Day ... Pennsylvania and help more Pennsylvanians with substance ... the Building Bridges to Recovery initiative. ... to a disease that is fully treatable, if given ...
(Date:8/31/2015)... Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest independent ... & CEO, and Sean Whelan , CFO, will present ... and Mr. Whelan are scheduled to participate in the Wells ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... participate in the Robert W. Baird 2015 Healthcare Conference in ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... LOS ANGELES--(BUSINESS WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. ... Phase,II data on the Company's prostate cancer drug ... Urological,Association (AUA) Annual Meeting, which is currently taking ... Dr. Timothy A.,Yap from the Cancer Research UK ...
... WIRE)--May 21, 2007 - Medical,professionals seeking to ... gram-negative pneumonia may have a new weapon:,NKTR-061 ... by Nektar Therapeutics (Nasdaq:NKTR)., Results of a ... of,NKTR-061 (Inhaled Amikacin) to treat mechanically ventilated,patients ...
Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 2Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 3Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 4Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 5Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 6Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 7Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 8Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 9Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 10Nektar Threraputics Announces Phase 2a Clinical Results Regarding,the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative,Hospital-Acquired Pneumonia Presented at the Annual American,Thoracic Society International Conference 11